KVUE:NYSE
Kenvue Inc
17,76 $
arrow_downward
−0,31%(−0,055) 1 p
17,75 $
arrow_downward
−0,06% (−0,010)bedtimePärast tööaega
Suletud: 13. okt, 16:00:05 GMT −4 · USD
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse KVUE põhistatistika genereerimine…
Ava
17,91 $
Kõrge
17,94 $
Madal
17,54 $
Turu kapit.
34,11 mld
Keskm. maht
24,19 mln
Maht
27,39 mln
Dividend
4,73%
Kvartaalne dividend
0,21 $
Dividendikuupäev
21. sept 2026
Hinna ja tulu suhe
20,59
52 näd kõrgeim
20,13 $
52 näd madalaim
14,02 $
Aktsiatulu
0,86 $
Beeta
0,48
Käibivad aktsiad
1,92 mld
Töötajate arv
22 tuh
Ava
17,91 $
Kõrge
17,94 $
Madal
17,54 $
Turu kapit.
34,11 mld
Keskm. maht
24,19 mln
Maht
27,39 mln
Dividend
4,73%
Kvartaalne dividend
0,21 $
Dividendikuupäev
21. sept 2026
Hinna ja tulu suhe
20,59
52 näd kõrgeim
20,13 $
52 näd madalaim
14,02 $
Aktsiatulu
0,86 $
Beeta
0,48
Käibivad aktsiad
1,92 mld
Töötajate arv
22 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
Reuters
·
8 tunni eest
EU approves Kimberly-Clark's $40 billion Kenvue acquisition
News Corp
·
9 tunni eest
Kimberly-Clark, Kenvue Win Conditional EU Approval for $40 Billion Tie-Up
Investing.com
·
9 tunni eest
Kimberly-Clark wins EU approval for Kenvue acquisition
Profiil
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey.
Johnson & Johnson announced in November 2021 that it would spin off its consumer health division as a separate company. The new company was named Kenvue in September 2022, and its initial public offering took place in May 2023, raising $3.8 billion in the largest U.S. IPO since 2021, with an initial valuation of about $41 billion. Johnson & Johnson initially retained more than 90% ownership before completing a full separation through a share exchange in July 2023. Kenvue was subsequently added to the S&P 500 Dividend Aristocrats index.
CEO Thibaut Mongon initially led Kenvue, which employed about 22,200 people in 2022. Following Mongon’s termination in 2025, Kirk Perry was named interim CEO. Wikipedia
Teave üksuse Kenvue Inc kohta
TegevjuhtKirk Perry
Töötajad21,9 tuh
Asutatud2022
PeakontoridSummit, New Jersey osariik, Ameerika Ühendriigid
SektorPersonal care products
Veebisaitkenvue.com